Alfter, Germany

Anna-Maria Eis-Hübinger


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anna-Maria Eis-Hübinger: Innovator in Anti-HSV Antibody Research

Introduction

Anna-Maria Eis-Hübinger is a prominent inventor based in Alfter, Germany. She has made significant contributions to the field of medical research, particularly in the development of antibodies for the treatment of herpes simplex virus (HSV) infections. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Anna-Maria's latest patents focus on an anti-HSV antibody. The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising an effective amount of the said antibody, an expression vector comprising a nucleotide sequence that encodes the said antibody, a host cell comprising the said nucleotide sequence, and a hybridoma cell capable of producing the said antibody. The use of this antibody as a drug, particularly for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject, is also defined in the claims.

Career Highlights

Throughout her career, Anna-Maria has worked with notable organizations such as Heidelberg Immunotherapeutics GmbH and Universität Duisburg Essen. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Anna-Maria has collaborated with esteemed colleagues, including Michael Roggendorf and Jürgen Krauss. These partnerships have further enriched her research endeavors and have led to impactful advancements in her field.

Conclusion

Anna-Maria Eis-Hübinger is a dedicated inventor whose work in anti-HSV antibody research is making a difference in the medical field. Her innovative contributions and collaborations highlight her commitment to advancing therapeutic solutions for HSV-associated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…